| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |